Votumumab

Revision as of 17:26, 20 August 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Votumumab
Monoclonal antibody
Type?
SourceTemplate:Infobox drug/mab source
Identifiers
CAS Number
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).

WikiDoc Resources for Votumumab

Articles

Most recent articles on Votumumab

Most cited articles on Votumumab

Review articles on Votumumab

Articles on Votumumab in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Votumumab

Images of Votumumab

Photos of Votumumab

Podcasts & MP3s on Votumumab

Videos on Votumumab

Evidence Based Medicine

Cochrane Collaboration on Votumumab

Bandolier on Votumumab

TRIP on Votumumab

Clinical Trials

Ongoing Trials on Votumumab at Clinical Trials.gov

Trial results on Votumumab

Clinical Trials on Votumumab at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Votumumab

NICE Guidance on Votumumab

NHS PRODIGY Guidance

FDA on Votumumab

CDC on Votumumab

Books

Books on Votumumab

News

Votumumab in the news

Be alerted to news on Votumumab

News trends on Votumumab

Commentary

Blogs on Votumumab

Definitions

Definitions of Votumumab

Patient Resources / Community

Patient resources on Votumumab

Discussion groups on Votumumab

Patient Handouts on Votumumab

Directions to Hospitals Treating Votumumab

Risk calculators and risk factors for Votumumab

Healthcare Provider Resources

Symptoms of Votumumab

Causes & Risk Factors for Votumumab

Diagnostic studies for Votumumab

Treatment of Votumumab

Continuing Medical Education (CME)

CME Programs on Votumumab

International

Votumumab en Espanol

Votumumab en Francais

Business

Votumumab in the Marketplace

Patents on Votumumab

Experimental / Informatics

List of terms related to Votumumab


Overview

Votumumab (marketed under the brand name HumaSPECT) is a human monoclonal antibody and which it is used to treat cancer.




Linked-in.jpg